期刊
NEUROSCIENCE LETTERS
卷 556, 期 -, 页码 37-41出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2013.09.059
关键词
Treatment-resistant schizophrenia; Brain-derived neurotrophic factor (BDNF); Matrix metalloproteinase-9 (MMP-9); Clozapine
资金
- Japanese Ministry of Health, Labor and Welfare [H22-seishin-ippan-010]
- Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [25461730, 23659565, 221S0003]
- Japan Foundation for Neuroscience and Mental Health
- Grants-in-Aid for Scientific Research [25861003] Funding Source: KAKEN
Brain-derived neurotrophic factor (BDNF) regulates the survival and growth of neurons, and influences synaptic efficiency and plasticity. Peripheral BDNF levels in patients with schizophrenia have been widely reported in the literature. However, it is still controversial whether peripheral levels of BDNF are altered in patients with schizophrenia. The peripheral BDNF levels previously reported in patients with schizophrenia were total BDNF (proBDNF and mature BDNF) as it was unable to specifically measure mature BDNF due to limited BDNF antibody specificity. In this study, we examined whether peripheral levels of mature BDNF were altered in patients with treatment-resistant schizophrenia. Matrix metalloproteinase9 (MMP-9) levels were also measured, as MMP-9 plays a role in the conversion of proBDNF to mature BDNF. Twenty-two patients with treatment-resistant schizophrenia treated with clozapine and 22 ageand sex-matched healthy controls were enrolled. The plasma levels of mature BDNF and MMP-9 were measured using ELISA kits. No significant difference was observed for mature BDNF however, MMP-9 was significantly increased in patients with schizophrenia. The significant correlation was observed between mature BDNF and MMP-9 plasma levels. Neither mature BDNF nor MMP-9 plasma levels were associated clinical variables. Our results do not support the view that peripheral BDNF levels are associated with schizophrenia. MMP-9 may play a role in the pathophysiology of schizophrenia and serve as a biomarker for schizophrenia. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据